Study of Artelon FLEXBAND® for Patients Undergoing Soft Tissue Reconstruction of the Anterior Talofibular Ligament (ATFL) to Treat Lateral Ankle Instability

Study Purpose

The goal of this clinical trial is to analzye return to pre-injury activity level on study participants with lateral ankle instability undergoing a modified Bröstrom reconstruction procedure for repair of the ATFL. Study participants undergoing ATFL reconstructive procedure using the ARTELON FLEXBAND System as an augmentation device will be compared to study participants undergoing a standard modified Bröstrom procedure alone. Clinician reported safety and functional outcomes measures will be collected at baseline; and at 2-, 6-, 12-, 18 and 26-weeks and 1- and 2-years post-surgery.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 18 Years - 75 Years
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

1. Subjects between and including the age of 18-75 at the time of surgery. 2. Subjects who were diagnosed with lateral ankle instability by physician clinical assessment. 3. Subjects who will undergo a modified Bröstrom procedure for an ATFL repair with or without FLEXBAND augmentation device (does not require an isolated repair). 4. Subjects that are able to understand, complete and sign the Consent Form.

Exclusion Criteria:

1. Significant secondary procedures done at the time of repair, including significant osteochondral lesions and/or significant microfracture of the talus or tibia that warrant modifying the typical lateral ligament repair post-op rehab protocol (minor microfractures and OCD lesions that do not warrant major bone debridement, synovectomies, and bone spur/osteophyte removals are allowed). 2. Any concomitant orthopedic procedure that will extend the post-op rehabilitation (e.g., casting/immobilization) beyond the routinely prescribed rehab protocol following an ATFL reconstructive procedure. 3. Subjects undergoing a Calcaneal osteotomy. 4. Subjects requiring major additional tendon surgery (i.e., peroneal tendon repair or tenodesis). 5. Neuropathy. 6. Subjects with diabetes, who, in the opinion of the investigator, are not sufficiently controlled. 7. BMI greater than 40 kg/m2. 8. Subjects with active Worker's Compensation Cases. 9. Any subject with a history of infection of the ankle predating the ankle repair. 10. Subjects with a systemic ligament laxity disorder (i.e., Ehlers-Danlos Syndrome). 11. Any orthopedic issue outside of the ankle that the Investigator feels may impede functional endpoint outcome measures. 12. Subjects who have a medical history that would likely make the subject an unreliable research participant. 13. Subjects that are nursing or pregnant at the time of surgery. 14. Subjects with physician assessed untreated alcohol or substance abuse at the time of screening. 15. Subjects who are currently enrolled or participated in another investigational device, drug, or biological trial within 60 days of screening.

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT06638138
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

N/A
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Stryker Trauma and Extremities
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Rebecca Gibson
Principal Investigator Affiliation Stryker Trauma & Extremities
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Industry
Overall Status Enrolling by invitation
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Lateral Ankle Instability
Arms & Interventions

Arms

Active Comparator: FLEXBAND

This group will undergo a lateral ankle ligament repair using the modified Broström technique with Artelon FLEXBAND augmentation of the ATFL.

No Intervention: Control

This group will undergo a lateral ankle ligament repair using the modified Broström technique. This technique utilizes anchors to repair the ATFL, in some cases the CFL, lateral ankle capsule and extensor retinaculum. This will be done without Artelon FLEXBAND augmentation.

Interventions

Device: - Flexband

Artelon FLEXBAND is a commercially available, polycaprolactone polyurethane urea (PCL/PUUR) multipolymer synthetic knitted mesh that is used for soft tissue reinforcement procedures. The device is biocompatible and degradable and has been used as an augmentation device in over 50,000 Orthopedic tendon and ligament reconstructive procedures. The FLEXBAND kits contain the device and all of the instrumentation needed to insert the device.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

MORE Foundation, Phoenix, Arizona

Status

Address

MORE Foundation

Phoenix, Arizona, 85023

University of Florida, Gainesville, Florida

Status

Address

University of Florida

Gainesville, Florida, 32607

Southeast Orthopedic Specialists, Jacksonville, Florida

Status

Address

Southeast Orthopedic Specialists

Jacksonville, Florida, 32204

OrthoCarolina Research Institute, Charlotte, North Carolina

Status

Address

OrthoCarolina Research Institute

Charlotte, North Carolina, 28207

Orthopedic Foot and Ankle Center, Worthington, Ohio

Status

Address

Orthopedic Foot and Ankle Center

Worthington, Ohio, 43085

Medical University of South Carolina, Charleston, South Carolina

Status

Address

Medical University of South Carolina

Charleston, South Carolina, 29425

UT Health Houson, Houston, Texas

Status

Address

UT Health Houson

Houston, Texas, 77030

The Center for Advanced Orthopedics, Falls Church, Virginia

Status

Address

The Center for Advanced Orthopedics

Falls Church, Virginia, 22042